| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Mar―05 |
Phytochemicals from Terminalia brownii and Acacia asak as natural inhibitors of SARS-CoV-2 main protease: In Vitro, molecular docking, and simulation analysis |
R A Mothana, W M Abdel-Mageed, Y T Alharbi, O A Basudan, M T Rehman, A A ElGamal, et al. (+3) A S Alqahtani, O I Fantoukh, M F AlAjmi |
| 2 |
[GO] |
2026―Mar―05 |
Investigation of natural products from medicinal cannabis as SARS-CoV-2 infectivity inhibitors |
R Bahij, S A Hansen |
| 3 |
[GO] |
2026―Mar―05 |
In silico approach on mechanisms of action by funicone-like fungal metabolites in Canine Coronavirus infection |
C Acconcia, L Del Sorbo, M M Salvatore, V Iovane, R Nicoletti, R Iacovino, et al. (+3) L Russo, F Fiorito, A Andolfi |
| 4 |
[GO] |
2026―Mar―05 |
Beyond the pandemic: Natural products against coronavirus cytokine storm |
O A Olajide |
| 5 |
[GO] |
2024―Dec―19 |
Pharmacological profiling of Hanshiyi formula, a herbal mixture used for the treatment of COVID-19 in China |
Stefanie Tiefenbacher, Patrik Schwarz, Alexander Perhal, Teresa Pirker, Eva-Maria Pferschy-Wenzig, Chensi Yao, et al. (+8) Chuanxi Tian, Weihao Wang, Yanyan Zhou, Hang Liu, Min Li, Verena Dirsch, Xiaolin Tong, Rudolf Bauer |
| 6 |
[GO] |
2024―Dec―19 |
Herbal Medicine Usage and Changes during the Covid-19 Pandemic: A representative Study in Germany |
Miriam Wolf, Agnes Emberger-Klein, Klaus Menrad |
| 7 |
[GO] |
2024―Dec―19 |
Fufang Yuxingcao Heiji for the treatment of COVID-19: clinical observations of a traditional Chinese preparation |
Kenny Kuchta, Xiaomei Li, Songhua Li, Zhuming Jin, Ruwei Wang, Silke Cameron |
| 8 |
[GO] |
2024―Dec―19 |
Narcissus pseudonarcissus L. and Narcissus poeticus L.: a source of antiviral compounds active against coronavirus |
Isabelle Ripoche, Maël Gainche, Marie Chastanet, Estelle Trouve, Pierre Chalard |
| 9 |
[GO] |
2024―Dec―19 |
Historical herbal texts from Switzerland: a potential source for plant- derived natural products against SARS-CoV-2 |
Nina Vahekeni, Corinna Urmann, Jonas Stehlin, Niklas Hofer, Yvonne Gmach, Evelyn Wolfram, Andreas Lardos |
| 10 |
[GO] |
2024―Dec―19 |
Cheminformatic and biochemometric strategies for the discovery of natural products against SARS-CoV-2 |
Benjamin Kirchweger, Andreas Wasilewicz, Ulrike Grienke, Judith M. Rollinger |
| 11 |
[GO] |
2024―Dec―19 |
Exploring the antiviral activity of flavonoids from Strychnos variabilis leaves against SARS-CoV-2 |
Allison Ledoux, Kristi Leka, Olivia Jansen, Olivier Bonnet, Carla Hamann, Luc Angenot, et al. (+2) Mutien-Marie Garigliany, Michel Frédérich |
| 12 |
[GO] |
2024―Jun―17 |
Cannabigerol and Cannabicyclol Block SARS-CoV-2 Cell Fusion |
Nica Classen, Thanet Pitakbut, Michael Schöfbänker, Joachim Kühn, Eike R. Hrincius, Stephan Ludwig, et al. (+2) Andreas Hensel, Oliver Kayser |
| 13 |
[GO] |
2023―Nov―14 |
The potential of anti-coronavirus plant secondary metabolites in COVID-19 drug discovery as an alternative to repurposed drugs: a review |
Zahra Alipour, Somayeh Zarezadeh, Ali Akbar Ghotbi-Ravandi |
| 14 |
[GO] |
2023―Jan―18 |
Short Lecture “Natural products against SARS-CoV-2 or how to catch a butterfly?” |
A Wasilewicz, B Kirchweger, D Bojkova, M Jose Abi Saad, J Langeder, M Bütikofer, et al. (+6) U Grienke, J Cinatl, J Orts, J Kirchmair, H Rabenau, J M Rollinger |
| 15 |
[GO] |
2023―Jan―18 |
Short Lecture “West Africa medicinal plants with activities against Sars-Cov-2 and other viruses” |
S Bordage, T Meunier, L Desmarets, M Bamba, K Hervouet, Y Rouillé, et al. (+10) N François, M Decossas, F H Tra Bi, O Lambert, P Vauchel, K Dimitrov, J Dubuisson, S Belouzard, S Sahpaz, K Séron |
| 16 |
[GO] |
2023―Jan―18 |
Keynote Lecture “Anti-viral Drug Discovery for Severe Acute Respiratory Syndrome (SARS-CoV-2)” |
R Quinn, M Liu, Y Gu, T Mak, E Belden |
| 17 |
[GO] |
2023―Jan―18 |
Traditional Chinese Medicine: A path worth exploring in the fight against COVID-19? |
K Leka, A Ledoux, P Desdemoustier, M-M Garigliany, M Frédérich |
| 18 |
[GO] |
2023―Jan―18 |
Echinacea for Prevention/Therapy of Respiratory Tract Infections during Covid-19 Pandemic: Insights from recent in vivo and in vitro Investigation |
R Weishaupt, E Kolev, R Vimalanathan, R Stange |
| 19 |
[GO] |
2023―Jan―18 |
Use of Natural Products During the COVID-19 Pandemic: An Exploratory Cross-Sectional Study in Saudi Arabia |
A Koshak, O Alghamdi, A Almoabdi, A Alahmadi |
| 20 |
[GO] |
2023―Jan―18 |
Impulse Lecture “Development of herbal medicines-example of APIVIRINE, a phytomedicine used for the treatment of COVID-19 in patients without signs of severity” |
S Ouedraogo, D Ouedraogo, G Tarnagda, J CRP Ouedraogo, H Hema, S Tiendrebeogo, et al. (+7) S Ouedraogo, G G Ouedraogo, L Belemnaba, N Ouedraogo, F B Kini, Z Tarnagda, M Ouedraogo |
| 21 |
[GO] |
2021―Oct―13 |
Activity of THC, CBD, and CBN on Human ACE2 and SARS-CoV1/2 Main Protease to Understand Antiviral Defense Mechanism |
Thanet Pitakbut, Gia-Nam Nguyen, Oliver Kayser |
| 22 |
[GO] |
2020―May―20 |
Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature |
Andreas Hensel, Rudolf Bauer, Michael Heinrich, Verena Spiegler, Oliver Kayser, Georg Hempel, Karin Kraft |
|
